Short description
Genprex is a clinical-stage biopharmaceutical company developing revolutionary immunogene therapies for cancer.
Description
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Austin, Texas, United States, North America
Founded on
January 1, 2009
Exited on
March 29, 2018
Went public on
March 29, 2018
Stock symbol
GNPX
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Cannot Access, Nopepepe
Sign in for full access
Founders
Rodney Varner